Endometriosis

Endometriosis Australia Partners with CHARLI App to Tackle Diagnosis Delays

Endometriosis, a condition impacting approximately 1 in 7 Australian females and individuals assigned female at birth (AFAB), presents significant challenges due to its debilitating symptoms and diagnostic complexities. In response to these challenges, the CHARLI app has been introduced in collaboration with Endometriosis Australia, aiming to enhance reproductive health tracking and management, particularly for those living with endometriosis. The initiative was spearheaded…

25% of Women Have Been Pressured Into Returning to Work Early After Health Issues, According to New Study

A recent study by women’s health startup frendo has uncovered alarming statistics revealing that a quarter of women in UK offices feel pressured or shamed into returning to work prematurely after health-related absences. These findings shed light on the pervasive obstacles faced by women in the workplace when dealing with health issues, indicating a significant lack of support and understanding from employers.…

Gynica Commences First-in-Human Clinical Trial for Novel IntraVag Treatment for Endometriosis

Gynica, a clinical-stage biotech startup focused on women’s health, has announced the initiation of a first-in-human Phase 1 clinical trial for a novel Endometriosis treatment. Led by renowned expert Prof. Felice Petraglia, the study aims to evaluate Gynica’s non-hormonal, intra-vaginal drug candidates using the IntraVag intra-vaginal drug delivery platform. Endometriosis, affecting over 200 million women worldwide, is characterized by the abnormal growth…

UK Hospital Initiates World-First Non-Hormonal Endometriosis Drug Trial

A pioneering drug trial has commenced at a UK hospital, marking a significant milestone in the quest for innovative endometriosis treatments. This Phase II research study, led by the Gynaecology and Research and Development team at NNUH, is examining the safety and effectiveness of a novel antibody, AMY109, developed by Chugai Pharmaceutical Co Ltd. Aimed at reversing the debilitating symptoms of endometriosis…

Serac Healthcare Presents Novel Imaging Approach for Endometriosis Diagnosis at SRI Annual Meeting

Serac Healthcare, a clinical radiopharmaceutical company, has made a significant stride in the diagnosis of endometriosis. The company has announced the preliminary results from the first patient cohort in the “Detecting Endometriosis expressed integrins using technetium-99m” (DETECT) study, focusing on the imaging of endometriosis using the innovative agent 99mTc-maraciclatide. These findings are set to be presented at the Society for Reproductive Investigation…

Pearsanta Acquires MDNA’s Mitomic Platform for Endometriosis and Ovarian Cancer Detection for $25M

Pearsanta, a subsidiary of Aditxt, has recently acquired the Mitomic testing platform from MDNA Life Sciences. The transaction, valued at approximately $25 million, is a strategic expansion for Pearsanta, enhancing its capabilities in early disease and cancer detection, particularly in women’s health, focusing on conditions such as endometriosis and ovarian cancer. The Mitomic technology utilizes mitochondrial DNA (mtDNA) to detect diseases at…

Hera Biotech to Acquire Endometriosis Diagnostic Assets from Scailyte in Move Towards Non-Surgical Diagnosis

In a stride towards non-surgical endometriosis diagnosis, Hera Biotech has announced its impending acquisition of endometriosis diagnostic assets from Scailyte, a company active in single-cell and AI-driven biomarker discovery. This acquisition marks a notable consolidation in the tissue-based diagnostic landscape for endometriosis, a prevalent condition contributing to a significant portion of female infertility and characterized by severe pain due to the abnormal…

CurE-me Project Joins BII’s Bio Studio to Advance Human Disease Models Specific to Endometriosis

Endometriosis, a debilitating disease affecting nearly 190 million women globally, has long been under-recognized and inadequately treated. The need for innovation in the field is evident, and a recent initiative from BioInnovation Institute (BII)‘s Bio Studio program might be a breakthrough. The CurE-me project, under the leadership of Professor Hugo Vankelecom from KU Leuven, seeks to unearth new therapeutic drugs to tackle…